2020
DOI: 10.1016/j.anndiagpath.2020.151478
|View full text |Cite
|
Sign up to set email alerts
|

Isolated tumor cells in the regional lymph nodes in patients with squamous cell carcinoma of the esophagus are rarely observed but often represent part of a true metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Because the lymphatic network between the esophagus and the mediastinum connects each other, lymph node metastasis can be not only continuous, but also bidirectional and skipped. 14,15 However, Liu Liang et al 16 have confirmed that total 2FLND can reduce the rate of lymph node metastasis. We believe that although total 2FLND increased the scope and number of dissected lymph nodes, the results of this study were affected in that lymph node metastasis of EC always occurs early, and most patients in this study were locally advanced.…”
Section: A H E a D O F P R I N Tmentioning
confidence: 99%
“…Because the lymphatic network between the esophagus and the mediastinum connects each other, lymph node metastasis can be not only continuous, but also bidirectional and skipped. 14,15 However, Liu Liang et al 16 have confirmed that total 2FLND can reduce the rate of lymph node metastasis. We believe that although total 2FLND increased the scope and number of dissected lymph nodes, the results of this study were affected in that lymph node metastasis of EC always occurs early, and most patients in this study were locally advanced.…”
Section: A H E a D O F P R I N Tmentioning
confidence: 99%
“…Esophageal cancer is one of the gastrointestinal malignancies with high morbidity and mortality because of its insidious symptoms, high malignancy, and powerful evasiveness [1][2][3]. Esophageal squamous cell carcinoma (ESCC) is the most common histological type [4], which is characterized by advanced diagnosis, metastasis, drug resistance, and frequent recurrence, and more than 50% of patients have unresectable tumors or metastatic lesions at the time of diagnosis [5]. Although the progresses of diagnosis and treatment technology have greatly improved the prognosis of ESCC patients in recent decades, the 5-year survival rate remains low at approximately 15-20% [4,6].…”
Section: Introductionmentioning
confidence: 99%